Discovering breast cancer drug candidates from biomedical literature.

Jiao Li,Xiaoyan Zhu,Jake Yue Chen
DOI: https://doi.org/10.1504/IJDMB.2010.033519
2010-01-01
International Journal of Data Mining and Bioinformatics
Abstract:We developed a new paradigm with the ultimate goal of enabling disease-specific drug candidate discovery with molecular-level evidences generated from literature and prior knowledge. We showed how to implement the paradigm by building a prototype literature-mining framework and performing drug-protein association mining for breast cancer drug discovery. In a molecular pharmacology study of breast cancer, 79.2% of 729 enriched drugs in 'Organic Chemicals' category were validated to be disease-related, and the remaining 20.8% were also investigated as potential for future molecular therapeutics studies. 'Doxorubicin', 'Etoposide' and 'Paclitaxel' were identified as having similar pharmacological profiles to treat breast cancer.
What problem does this paper attempt to address?